Definitive Contract HHSN261201000059C

This is a $37,262,683.59 definitive cost-no-fee contract awarded by the National Cancer Institute (NCI) to The International Genomics Consortium. The contract is for providing biospecimen processing services to support the Cancer Genome Atlas (TCGA) program, which is part of the National Institutes of Health's efforts to comprehensively characterize various cancer types. The contract has an ultimate completion date of December 30, 2012 and was awarded on September 24, 2010 as part of the...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The total ceiling value of the contract is $42,000.00. This contract is part of the NCI's Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract...

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. for the Cancer Genome Atlas (TCGA) program. The $1,337,077.50 contract is to provide tissue samples and data from various types of cancer for the TCGA program, which aims to characterize the genomic changes involved in cancer. The award is not associated with a set-aside program. This delivery order is part of...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to Yale University. The contract is to support the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer, as part of the American Recovery and Reinvestment Act (ARRA). The contract has a ceiling value of $76,875 and a period of performance ending on March 31, 2015. This contract was...

This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...

This is a $7,387,184.42 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), a civilian agency, to Analytical Biological Services Inc. (ABS) on September 27, 2010. The contract supports the Cancer Genome Atlas (TCGA) program and is funded through the American Recovery and Reinvestment Act (ARRA). ABS will serve as a Tissue Source Site (TSS) network in support of TCGA, which is a joint effort of the National Cancer Institute and the National Human Genome Research Institute...

This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Ilsbio LLC, a for-profit limited liability company. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This award is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and is funded under the American Recovery and Reinvestment Act (ARRA). The contract has a...

This is a $161,250 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to The Johns Hopkins University (JHU) for the Cancer Genome Atlas (TCGA) program. The order is part of a larger NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The work involves providing tissue samples and data from various cancer types to support the TCGA, a collaborative effort to accelerate the understanding of the molecular basis of cancer through the application of genome...

This is a Firm Fixed Price Delivery Order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Indivumed, Inc., a For Profit Organization. The contract is for the recovery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The potential value of this contract is $38,000.00. It is not associated with a set-aside designation. The contract is issued under the NCI Cancer Genome...

This federal contract award, with an ID of HHSN261201000018I|HHSN26100001, was issued by the National Cancer Institute (NCI) to The GOG Foundation, Inc., a non-profit organization, to support the Cancer Genome Atlas (TCGA) program. The contract, which has a firm fixed price of $123,496.76 and a completion date of September 30, 2014, is a delivery order under the NCI Cancer Genome Atlas Program Tissue Purchase master indefinite delivery, indefinite quantity (IDIQ) contract. The contract does...